Fluence Corporation Ltd announced the first commercial Aspiral sale in the USA

FLC ASX Kalkine Media

Achieved the first commercial Aspiral sale in the USA: Fluence Corporation Ltd (ASX: FLC), that offers an integrated range of services across the complete water cycle, from early stage evaluation, through design and delivery to ongoing support and optimization of water related assets, stock rose 2.63% on August 07, 2018. The company has achieved the first commercial sale of its Aspiral Smart Packaged Wastewater Treatment Plant in the USA and is based on FLC’s innovative Membrane Aerated Biofilm Reactor (MABR) technology.

The Aspiral L + Ultrafiltration (UF) plant is designed for client WaterFleet, LLC and  will be deployed at an LNG worksite in Texas’ Gulf Coast region. The plant has short implementation timeline with commissioning expected by January 2019. The plant will treat 33,000 gallons per day of wastewater. This is decentralized wastewater treatment plant, that can serve as both a mobile or permanent installation, therefore will be relocated by WaterFleet as required to meet its treatment needs. Moreover, FLC sees opportunities in this market and a strong growth potential for other MABR-based products. The company expects WaterFleet and other US-based companies will be able to capitalize on the significant advantages of the technology. Meanwhile, FLC stock has fallen 17.39% in three months as on August 06, 2018.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

Sponsored ad by Kalkine

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here